Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMFIBROZIL vs GILTERITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMFIBROZIL vs GILTERITINIB: Safety Overview

Metric GEMFIBROZIL GILTERITINIB
Total FAERS Reports 1,089 3,672
Deaths Reported 101 1,014
Death Rate 9.3% 27.6%
Hospitalizations 286 1,407
Average Patient Age 56.7 yrs 60.8 yrs
% Female Patients 49.9% 48.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Nov 28, 2018
Manufacturer Northwind Health Company, LLC Astellas Pharma US, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription